Pediatrix Medical (MD) Short term Debt (2009 - 2026)

Pediatrix Medical (MD) has reported Short term Debt for 14 consecutive years, with $186.2 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Short term Debt rose 686.08% year-over-year to $186.2 million in Q2 2026; TTM through Jun 2026 was $186.2 million, a 686.08% increase from a year earlier, with the FY2025 full-year figure at $26.8 million, up 30.47% from the prior year.
• Short term Debt was $186.2 million for Q2 2026 at Pediatrix Medical, down from $192.4 million in the prior quarter.
• Over five years, Short term Debt peaked at $301.0 million in Q1 2022 and troughed at $14.9 million in Q4 2022.
• A 5-year average of $53.1 million and a median of $18.5 million in 2024 frame the typical range for Short term Debt.
• Across the five-year window, Short term Debt slumped 95.05% in 2023 and jumped 769.58% in 2026, its largest moves.
• Over 5 years, Short term Debt stood at $14.9 million in 2022, then increased by 0.1% to $14.9 million in 2023, then soared by 37.77% to $20.5 million in 2024, then surged by 30.47% to $26.8 million in 2025, then soared by 594.56% to $186.2 million in 2026.
• The last three Short term Debt figures came in at $186.2 million (Q2 2026), $192.4 million (Q1 2026), and $26.8 million (Q4 2025), per Business Quant data.